1Liang X,Lijian H,Shaohui W,et al,Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma,Cancer Res,2001,61:3176-3181.
4Arsdorp N, Elderson A, Wittebol-Post D, et al. Von Hippel-Lindau disease:new strategies in early detection and treatment. Am J Med, 1994,97 : 158-168.
5Lath B, Gregor A, Rippstein P, et al. Angiogenic histogenesis of stroreal cells in hemangioblastomazultrastructural and immunohistochemical study. Ultrastruct Pathol, 1999,23:299-310.
6Vortmeyer AO, Gnarra JR, Emmert-Buck MR,et al, Von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with yon Hippel-Lindau disease. Human Pathology, 1997,28:540-543.
7Vortmeyer AO, Frank S ,Jeong S, et al. Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease, Cancer Res,2003,63:7051-7055.
8Wiesener MS, Eckardt KU. Erythropoietin,tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing. Nephrol Dial Transplant,2002,17:356-359.
9Marion K, Hugo HM, Karl HP. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with yon Hippel-Lindau tumor suppressor gene loss of function. Blood, 1998,92:3388-3393.
10Berkman RA, Merrill MJ, Reinhold WC, et al. Expression of the vascular permeability factor/vascular endothelial growth faetor gene in central nervous system neoplasms. J Clin Invest, 1993,91 : 153.
